Skip to main content
SHANGHAI MICROPORT EP MEDTECH CO., LTD. logo

SHANGHAI MICROPORT EP MEDTECH CO., LTD. — Investor Relations & Filings

Ticker · 688351 ISIN · CNE100005PG9 Shanghai Stock Exchange Manufacturing
Filings indexed 362 across all filing types
Latest filing 2025-03-27 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688351

About SHANGHAI MICROPORT EP MEDTECH CO., LTD.

https://www.everpace.com/

SHANGHAI MICROPORT EP MEDTECH CO., LTD. focuses on the research, development, and commercialization of medical devices for cardiac electrophysiology. The company provides a comprehensive suite of products for the diagnosis and treatment of cardiac arrhythmias, including 3D cardiac mapping systems, diagnostic catheters, and radiofrequency ablation catheters. Its core technology, the Columbus 3D EP Navigation System, enables precise localization and visualization of catheters within the heart. The product line also encompasses irrigation pumps and ablation generators designed to support minimally invasive procedures. The company aims to deliver integrated solutions that improve clinical outcomes for patients with rhythm disorders through advanced mapping and therapeutic technologies.

Recent filings

Filing Released Lang Actions
2024年董事会审计委员会履职报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2024 Board Audit Committee Performance Report" of Shanghai MicroPort EP MedTech Co., Ltd. It details the activities, meetings, and evaluations conducted by the Board Audit Committee during 2024, including oversight of external auditors, review of financial reports, internal control assessments, and related governance matters. The document is a committee report on its own performance and oversight activities rather than a full audit report or annual report. It does not contain full financial statements or detailed audit opinions but rather a summary of the committee's work and evaluations. This fits the category of Audit Report / Information (AR), which includes standalone audit-related reports and committee oversight reports. The document length is 2581 characters, which is consistent with a detailed committee report but not a full annual report. Therefore, the classification is AR with high confidence. FY 2024
2025-03-27 Chinese
关于首次实现盈利暨取消股票简称标识U的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Shanghai MicroPort EP MedTech Co., Ltd. regarding the cancellation of the special 'U' stock abbreviation that was previously assigned due to the company being unprofitable at listing. It references audited financial results for 2024 and the board's approval of the annual report, but the document itself is not the annual report or financial statements. The document is short (1007 characters) and serves to inform shareholders and the market about the change in stock designation following the company's first profitable year. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about stock listing status and does not contain the full annual report or detailed financial data itself.
2025-03-27 Chinese
第三届监事会第十四次会议决议公告
Report Publication Announcement Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Shanghai MicroPort EP MedTech Co., Ltd. It details the approval of various reports and proposals related to the 2024 fiscal year, including the 2024 Annual Report, Internal Control Evaluation Report, Financial Final Report, and other related disclosures. The document repeatedly states that these reports have been disclosed on the Shanghai Stock Exchange website and that the proposals will be submitted to the shareholders' meeting for approval. The document itself does not contain the full annual report or detailed financial statements but rather summarizes the resolutions passed by the Supervisory Board and references the full reports available elsewhere. The document length is about 3103 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the "Menu vs Meal" rule, this document is an announcement of the publication and approval of the annual report and related documents, not the annual report itself. Hence, the correct classification is Report Publication Announcement (RPA).
2025-03-27 Chinese
关于2025年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the company's expected related party transactions for the fiscal year 2025. It includes information about the nature of the transactions, the amounts involved, the related parties, the approval process by the board and audit committee, and the necessity and fairness of the transactions. It also includes the sponsor's verification opinion and references to regulatory compliance. The document is not a financial report like an annual or interim report, nor is it a simple announcement of a report publication. It is a regulatory announcement about related party transactions, which is a typical regulatory filing. There is no indication that this is a management change, earnings release, or other specific category. Therefore, the best fit is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-03-27 Chinese
2024年年度报告摘要
Annual Report Classification · 98% confidence The document is titled as "2024 年年度报告摘要" which translates to "2024 Annual Report Summary". It contains detailed financial data including total assets, net profit, revenue, quarterly financial data, shareholder information, business overview, industry analysis, and risk factors. The length of the document is over 14,000 characters, indicating it is a substantive report rather than a brief announcement. The content includes comprehensive financial performance and management discussion, consistent with an Annual Report. There is no indication that this is merely an announcement or a certification. Therefore, the document fits the definition of an Annual Report (10-K). FY 2024
2025-03-27 Chinese
2024年度环境、社会和公司治理报告
Environmental & Social Information Classification · 100% confidence The document is titled "微电生理2024 年度环境、社会和公司治理报告" which translates to "MicroPort EP MedTech 2024 Annual Environmental, Social and Corporate Governance Report." It covers ESG (Environmental, Social, and Governance) topics extensively, including governance structure, environmental compliance, energy use, pollution control, and social responsibility. The report period is the full year 2024 (January 1 to December 31, 2024). The document is about 15,000 characters long, indicating a full report rather than a brief announcement. The content focuses on ESG performance and governance rather than financial results or management changes. This matches the definition of an Environmental & Social Information report (ESG report). Therefore, the correct classification is "SR" (Environmental & Social Information).
2025-03-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.